Cupertino, CA, United States of America

Sarni Karaborni

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Xenoport, Inc.. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sarni Karaborni

Introduction

Sarni Karaborni is an accomplished inventor based in Cupertino, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. Her innovative work has led to the creation of a unique prodrug formulation that enhances therapeutic efficacy.

Latest Patents

Sarni holds a patent for "Sustained release oral dosage forms of an R-baclofen prodrug." This patent focuses on the sustained release of R-baclofen, which is crucial for improving patient compliance and therapeutic outcomes. The patent showcases her expertise in drug formulation and delivery systems. She has 1 patent to her name.

Career Highlights

Sarni Karaborni has built a successful career at Xenoport, Inc., where she has been instrumental in advancing drug development projects. Her work has not only contributed to the company's portfolio but has also had a positive impact on patient care through innovative drug solutions.

Collaborations

Throughout her career, Sarni has collaborated with notable colleagues, including David E. Edgren and David J. Kidney. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sarni Karaborni's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in drug development. Her work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…